According to this observation, individuals with heterozygous NPC1 mutations have been found to have an increased risk of parkinsonism or dementia [7], and several studies have discovered monoallelic NPC1 mutations in cohorts of patients with dementia and brain amyloid deposition [8, 9]. The gene discussed is NPC1; the disease is Parkinsonism.